The challenges faced in developing novel drug radiation combinations in non-small cell lung cancer

Harrow, S., Hanna, G.G., Faivre-Finn, C., McDonald, F. and Chalmers, A. (2016) The challenges faced in developing novel drug radiation combinations in non-small cell lung cancer. Clinical Oncology, 28(11), pp. 720-725. (doi: 10.1016/j.clon.2016.08.004) (PMID:27591000)

[img]
Preview
Text
128261.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

577kB

Abstract

Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Chalmers, Professor Anthony
Authors: Harrow, S., Hanna, G.G., Faivre-Finn, C., McDonald, F., and Chalmers, A.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Clinical Oncology
Publisher:Elsevier
ISSN:0936-6555
ISSN (Online):1433-2981
Published Online:31 August 2016
Copyright Holders:Copyright © 2016 Elsevier
First Published:First published in Clinical Oncology 28(11):720-725
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record